首页> 美国卫生研究院文献>other >Hypersensitivity Reactions: Priming practice change to reduce incidence in first-dose rituximab treatment

【2h】

Hypersensitivity Reactions: Priming practice change to reduce incidence in first-dose rituximab treatment

机译：超敏反应：改变用药方法以减少首剂利妥昔单抗治疗的发生率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Rituximab is a widely used anti-cancer treatment with a high incidence of hypersensitivity reaction (HSR). Strategies to reduce the incidence of HSR include premedications and slow titration. There is a lack of literature reporting on the priming method used when preparing rituximab intravenous lines and the potential impact on incidence of HSR.

机译：背景：利妥昔单抗是一种广泛使用的抗癌治疗药物，其超敏反应（HSR）的发生率很高。减少高铁发生率的策略包括预防用药和缓慢滴定。缺乏文献报道制备利妥昔单抗静脉输注线时使用的引发方法及其对高铁发生率的潜在影响。

著录项

期刊名称 other
作者
Carissa Laudati; Caroline Clark; Andrea Knezevic; Zhigang Zhang; Margaret Barton-Burke;
展开▼
作者单位

展开▼
年(卷),期 -1(22),4
年度 -1
页码 407–414
总页数 16
原文格式 PDF
正文语种
中图分类
关键词
Rituximab Cytokine release syndrome Priming Hypersensitivity Reaction or HSR Intravenous lines;

机译：利妥昔单抗;细胞因子释放综合征;引发;超敏反应或HSR;静脉注射;

相似文献

外文文献
中文文献
专利

1. Hypersensitivity Reactions: Priming Practice Change to Reduce Incidence in First-Dose Rituximab Treatment. [J] . Carissa Laudati, Caroline Clark, Andrea Knezevic, Clinical journal of oncology nursing . 2018,第4期

机译：超敏反应：引发实践改变以减少第一剂量蓖麻毒素治疗的发病率。
2. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test? [J] . Elisa Piva, Fulvia Chieco-Bianchi, Valentino Krajcar, AMERICAN JOURNAL OF HEMATOLOGY . 2012,第11期

机译：利妥昔单抗联合治疗期间B细胞淋巴瘤患者的不良反应：嗜碱性粒细胞活化试验体外评估利妥昔单抗超敏反应？
3. Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy [J] . Parinyanitikul Napa, Tanpipattanakul Walailuk, Poovorawan Nattaya, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2018,第7期

机译：在早期乳腺癌患者中预筛选出在早期乳腺癌患者的患者中未经历过两次紫杉醇化疗的患者的患者患者的患者发生过敏反应率
4. Structural changes in the irradiated dentin with Nd:YAG and Er:YAG lasers for cervical hypersensitivity treatment and their influence on the microtensile resistance in resin-dentin interface [C] . Claudia C. B. O. Mota, Tatiane V. N. S. Sena, Roseane F. Castro, Lasers in dentistry XXII . 2016

机译：Nd：YAG和Er：YAG激光照射的牙本质对宫颈超敏反应的结构变化及其对树脂-牙本质界面抗微张力的影响
5. Lactobacillus reuteri reduces visceral hypersensitivity and alters gut motility without changing gut serotonin availability in an animal model of the irritable bowel syndrome. [D] . Jakupovic, Jasmina. 2013

机译：在肠易激综合征的动物模型中，路氏乳杆菌可降低内脏超敏反应并改变肠蠕动，而不会改变肠内5-羟色胺的利用率。
6. Lower dose and lower injection speed of iodinated contrast media: a new strategy to reduce the incidence rate of immediate hypersensitivity reactions [O] . Ingrid B. Böhm 2020

机译：碘造影剂的更低剂量和更低注射速度：降低即时超敏反应发生率的新策略
7. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test. [O] . Piva E, Chieco-Bianchi F, Krajcar V, 2012

机译：利妥昔单抗联合治疗期间B细胞淋巴瘤患者的不良反应：通过嗜碱性粒细胞活化试验体外评估利妥昔单抗超敏反应。

Hypersensitivity Reactions: Priming practice change to reduce incidence in first-dose rituximab treatment

摘要

著录项

相似文献

相关主题

期刊订阅